@jeffowski
As long as it is clear that disagreements can be had about the interpretations of the data collection. Of course.
Conversation
Notices
-
Embed this notice
RaymondPierreL3 (raymondpierrel3@aus.social)'s status on Friday, 06-Sep-2024 12:13:30 JST RaymondPierreL3
-
Embed this notice
Church of Jeff (jeffowski@mastodon.world)'s status on Friday, 06-Sep-2024 12:13:30 JST Church of Jeff
@RaymondPierreL3 -- And an application of proper study parameters.
I am a proponent of MDMA and Psilocybin for PTSD treatment and when the FDA declined to move their stance on MDMA (not Psilocybin) being ineffective, the study used had some major flaws and you can see why the FDA didn't approve it as a treatment for PTSD. Better science is the only way forward.
-
Embed this notice